期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

原发性早期乳腺癌保乳手术后五年原位复发特点分析 被引量：3

原文传递
导出
摘要 目的总结原发性早期乳腺癌保乳手术后5年原位复发的特点。方法2000年5月至2005年5月保乳手术治疗原发性早期乳腺癌47例，行象限切除加腋窝淋巴结清扫39例，单纯肿块局部广泛切除术无腋窝淋巴结清扫8例，其中术后行全乳切线加瘤床放疗40例。结果随访5—10（7．0±1．5）年，原位复发3例，占6．4％（3／47），均为非浸润性癌。术后行全乳切线加瘤床放疗者原位复发率（2．5％，1／40）低于未行全乳放疗者（28．6％，2P）（P=0．035），行象限切除加腋窝淋巴结清扫者原位复发率（2．6％，1，39）低于行单纯肿块局部广泛切除术无腋窝淋巴结清扫者（25．0％，2／8）（P=0．029）。结论原发性早期乳腺癌保乳手术后放疗及象限切除加腋窝淋巴结清扫是必要的，可降低5年原位复发率。
作者 郭文利 喻其霞
机构地区 浙江省嘉兴市第一人民医院乳腺科
出处 《中国医师进修杂志》 2011年第20期62-63,共2页 Chinese Journal of Postgraduates of Medicine
关键词 乳腺肿瘤 复发 全乳放疗 保乳手术
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1甘霖霖,郭文斌,张月秋.早期乳腺癌保乳手术52例分析[J].中国微创外科杂志,2006,6(9):669-670. 被引量：3
  • 2Huang E,Buchholz TA,Meric F,et al.Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.Cancer, 2002,95( l0 ) : 2059-206%.
  • 3王淑莲.乳腺癌保留乳房手术后的放射治疗技术[J].中华乳腺病杂志（电子版）,2010,4(3):23-27. 被引量：4
  • 4Reitsamer R,Peintinger F,Sedlmayer F,et al.Acce|erated partial breast irradiation after conservative surgery for breast cancer.Ann Surg, 2005,242( 1 ) : 147-148.
  • 5金今月,许明吉.早期乳腺癌保乳术加辅助治疗临床观察[J].中国现代医生,2010,48(25):139-140. 被引量：1
  • 6Hannoun-Levi JM,Ferr6 M,Raoust I,et al. Accelerated pa~ial breast irradiation using interstitial high dose rate brachytherapy: preliminary clinical and dosimetrie results after 61 patients. Cancer Radiother, 2008,12( 6/7 ) : 532-540.

二级参考文献52

  • 1程琳,乔新民,杨德启,佟富中,周波,曹迎明,刘鹏,刘宏军,王殊,刘淼,张嘉庆.乳腺癌保乳手术治疗148例分析[J].中国微创外科杂志,2004,4(4):276-278. 被引量：43
  • 2杨名添,戎铁华,黄植蕃,曾灿光,龙浩,傅剑华,林鹏,王欣,王思愚,王曦,唐军.可手术乳腺癌6263例临床分析[J].癌症,2005,24(3):327-331. 被引量：46
  • 3McDonald MW,Godette KD,Whitaker DJ,et al.Three-Year Outcomes of Breast Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost.Int J Radiat Oncol Biol Phys,2009,77:523-530.
  • 4Raiyawa T,Lertbutsayanukul C,Rojpornpradit P.Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up.J Med Assoc Thai,2009,92:390-397.
  • 5Sharma R,Spierer M,Mutyala S,et al.Change in seroma volume during whole-breast radiation therapy.Int J Radiat Oncol Biol Phys,2009,75:89-93.
  • 6Prendergast B,Indelicato DJ,Grobmyer SR,et al.The dynamic tumor bed:volumetric changes in the lumpectomy cavity during breast-conserving therapy.Int J Radiat Oncol Biol Phys,2009,74:695-701.
  • 7Clarke M,Collins R,Darby S,et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials.Lancet,2005,366:2087-2106.
  • 8Solin LJ,Chu JC,Sontag MR,et al.Three-dimensional photon treatment planning of the intact breast.Int J Radiat Oncol Biol Phys,1991,21:193-203.
  • 9Raj KA,Evans ES,Prosnitz RG,et al.Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? Cancer J,2006,12:309-317.
  • 10Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med,2002,347:1233-1241.

共引文献5

同被引文献33

  • 1李建彬,卢洁,范廷勇,刘娟,白瞳,孙涛,邢军,王永胜,邵倩.乳腺癌保乳术后全乳加瘤床补量照射不同治疗计划的比较[J].中华放射医学与防护杂志,2008,28(2). 被引量：8
  • 2王志震,李瑞英.早期乳腺癌保乳手术后10年局部复发与部分乳腺放疗[J].中国肿瘤临床,2006,33(20):1188-1191. 被引量：7
  • 3Li XM, Yah H, Zhou KN, et al. Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial[J]. Breast Cancer Res Treat, 2011,128(2):411-419.
  • 4Maddox WA, Carpenter JT Jr, Laws HL, et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients[J]. Ann Surg, 1983, 198(2):207-212.
  • 5Abdulkarim BS, Cuartero J, Hanson J, et al. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy[J]. J Clin Oncol, 2011, 29(21):2852-2858.
  • 6Ellis MJ, Dixon M, Dowsett M, et al. A luminal breast cancer genome atlas: progress and barriers[J]. J Steroid Biochem Mol Biol, 2007. 106(1-5):125-129.
  • 7Sanpaolo P, Barbieri V, Genovesi D. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study[J]. Eur J Surg Oncol, 2011, 37(10):876-882.
  • 8Ellis MJ, Coop A, Singh B, et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1 and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial[J]. J Clin Oncol, 2001, 19(18):3808-3816.
  • 9Stickeler E, Pils D, Klar M, et al. basal-like molecular subtype and HER2 up-regulation and response to neoadjuvant chemotherapy in breast cancer[J]. Oncol Rep, 2011, 26(4):1037-1045.
  • 10Foulkes WD, Brunet JS, Stefansson IM, et al. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/ glomeruloid-microvascular-proliferation+) phenotype of BRCA1- related breast cancer[J]. Cancer Res, 2004, 64(3):830-835.

引证文献3

二级引证文献17

中国医师进修杂志
2011年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部